Antitrust Antitrust

Medical suppliers may coordinate to avoid shortages, EU antitrust guidance says

By Michael Acton
  • 08 Apr 2020 06:16
  • 08 Apr 2020 06:41

Pharmaceutical and other companies may coordinate their activities to address potential medical supply shortages in certain circumstances during the Covid-19 pandemic, even where this would usually breach antitrust rules, the European Commission has said.

A new Temporary Framework Communication “is meant to provide antitrust guidance to companies willing to temporarily cooperate

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News